Vivo Bio Tech Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 161.599 million compared to INR 143.792 million a year ago. Net income was INR 2.975 million compared to net loss of INR 4.058 million a year ago. Basic earnings per share from continuing operations was INR 0.22 compared to basic loss per share from continuing operations of INR 0.31 a year ago. For the full year, total revenue was INR 518.538 million compared to INR 554.054 million a year ago. Net income was INR 56.823 million compared to INR 44.415 million a year ago. Basic earnings per share from continuing operations was INR 4.23 compared to INR 3.45 a year ago. Diluted earnings per share from continuing operations was INR 4.19 compared to INR 3.45 a year ago.